Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Long-Term Investments: 2023-2024

Historic Long-Term Investments for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Dec 2024 value amounting to $38.9 million.

  • Zhengye Biotechnology Holding's Long-Term Investments rose 2.66% to $38.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $38.9 million, marking a year-over-year increase of 2.66%. This contributed to the annual value of $38.9 million for FY2024, which is 0.76% up from last year.
  • Per Zhengye Biotechnology Holding's latest filing, its Long-Term Investments stood at $38.9 million for FY2024, which was up 0.76% from $38.6 million recorded in FY2023.
  • Zhengye Biotechnology Holding's Long-Term Investments' 5-year high stood at $38.9 million during FY2024, with a 5-year trough of $38.6 million in FY2023.
  • In the last 2 years, Zhengye Biotechnology Holding's Long-Term Investments had a median value of $38.8 million in 2023 and averaged $38.8 million.
  • Data for Zhengye Biotechnology Holding's Long-Term Investments shows a peak YoY climbed of 0.76% (in 2024) over the last 5 years.
  • Over the past 2 years, Zhengye Biotechnology Holding's Long-Term Investments (Yearly) stood at $38.6 million in 2023, then increased by 0.76% to $38.9 million in 2024.